Eylea (Regeneron Pharmaceuticals)
(https://eylea.us) 📸 Data Snapshot: May 30, 2026Count trust words (review, testimonial, rating, verified) against real outbound proof links (Google, Trustpilot, Clutch, G2, Yelp). Lots of trust language with zero verification links is trust theatre. Unlinked logo galleries count against it.
The review_count and proof_links_count are both zero, indicating a complete lack of verified trust signals or external validation. No performance claims are made in the text, so no active ‘trust theatre’ is detected; however, the site fails to provide a single proof path to regulatory filings or clinical trial data. This absence of outbound validation for a medical product results in a maximum proof path penalty. The site essentially functions as a verification vacuum.
The ratio of verifiable evidence to assertions is undefined, as the site contains neither. There are exactly zero proof points present across the page data, against an industry expectation of dense clinical and regulatory citations. The only verifiable data points are technical error metrics, which provide zero evidence regarding the efficacy or safety of the pharmaceutical product the domain represents.
Trust & Proof is read by weighing trust language against real verification. Below is the page-by-page tally of review mentions and external proof links, then the schema markup that may (or may not) declare verifiable ratings and identity proof.
🛡️ Trust Signals — reviews, proof links, trust-theatre check
| Page | Reviews | Proof links |
|---|---|---|
| / (home) | 0 | 0 |
🔗 Identity & Technical Layer — schema JSON-LD: declared ratings, reviews & identity proof
This page presents a snapshot of public data from Eylea (Regeneron Pharmaceuticals), captured on May 30, 2026, to show how machine logic reads Trust & Proof signals into an AI reputation evaluation.
Purpose: This data is presented under “Fair Use” for the purpose of independent signal analysis, allowing readers to see the raw signals behind the reputation score.
Notice to Eylea (Regeneron Pharmaceuticals): This analysis is part of a non-adversarial audit conducted by 1 Euro SEO. The results are intended as professional feedback to help improve any website’s machine-readability and authority signals. The evaluation is free, and any company can request a fresh audit at any time.
Any company can use the insights for free and improve its voice. When a company has updated its content, it can always submit a new audit request, which will be reflected in a new current score.
To all users: You are encouraged to visit the live site at https://eylea.us to view the most current version of its content and see directly what this company is about and what it offers.